Oral Type I Collagen for Relieving Scleroderma
Public ClinicalTrials.gov record NCT00005675. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multicenter Phase II Trial of Oral Type I Bovine Collagen in Scleroderma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Diffuse systemic sclerosis (SSc), or scleroderma, is a connective tissue disease causing damage to skin and other organs. The purpose of this study is to determine if taking oral bovine type I collagen (CI) will improve the condition of SSc patients.
Study identification
- NCT ID
- NCT00005675
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 168 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2000 (Type not available)
- Primary completion
- May 2005 (Actual)
- Completion
- Not listed
- Last update posted
- May 25, 2010
Started 2000
United States locations
- U.S. sites
- 12
- U.S. states
- 12
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35294 | — |
| University of California Los Angeles | Los Angeles | California | 90024 | — |
| University of Connecticut | Farmington | Connecticut | 06030-1310 | — |
| Georgetown University Medical Center | Washington D.C. | District of Columbia | 20007 | — |
| Johns Hopkins University | Baltimore | Maryland | 21224 | — |
| Boston University School Of Medicine | Boston | Massachusetts | 02188 | — |
| Wayne State University | Detroit | Michigan | 48201 | — |
| Beth Israel Medical Center | New York | New York | 10003 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| University of Tennessee Health Science Center | Memphis | Tennessee | 38163 | — |
| The University of Texas Health Science Center at Houston | Houston | Texas | 77030 | — |
| Virginia Mason Research Center | Seattle | Washington | 98101 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00005675, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 25, 2010 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00005675 live on ClinicalTrials.gov.